Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis

Pediatric Infectious Disease Journal

Volumn 23, Issue 7, 2004, Pages 608-613

  Van Der Flier, Michiel ^a,b   Hoppenreijs, Sharon ^a   Van Rensburg, Anita Janse ^d   Ruyken, Maartje ^b   Kolk, Arend H J ^c   Springer, Priscilla ^d   Hoepelman, Andy I M ^b   Geelen, Sibyl P M ^a   Kimpen, Jan L L ^a   Schoeman, Johan F ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ROYAL TROPICAL INSTITUTE   (Netherlands)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Blood brain barrier; Corticosteroids; Mycobacterium tuberculosis; Tuberculous meningitis; Vascular endothelial growth factor

Indexed keywords

ACETAZOLAMIDE; CORTICOSTEROID; DEXAMETHASONE; ETHIONAMIDE; FUROSEMIDE; ISONIAZID; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN; SERUM ALBUMIN; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADOLESCENT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD SAMPLING; BRAIN EDEMA; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HYDROCEPHALUS; INFANT; INTRACRANIAL HYPERTENSION; LIMULUS LYSATE TEST; MALE; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULOUS MENINGITIS;

ALBUMINS; ANTITUBERCULAR AGENTS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCEPHALUS; INFANT; INTRACRANIAL PRESSURE; MALE; PREDNISONE; SEVERITY OF ILLNESS INDEX; TUBERCULOSIS, MENINGEAL; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 3142752595     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000131634.57368.45     Document Type: Article

References (32)

1. Schoeman JF, Van Zyl LE, Laubscher JA, Donald PR. Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis. Pediatrics. 1997;99:226-231.
2. Schoeman J, Wait J, Burger M, et al. Long-term follow up of childhood tuberculous meningitis. Dev Med Child Neurol. 2002;44:522-526.
3. Thwaites G, Chau TT, Mai NT, Drobniewski F, McAdam K, Farrar J. Tuberculous meningitis. J Neurol Neurosurg Psychiatry. 2000;68:289-299.
4. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement: global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA. 1999;282:677-686.
5. Tsenova L, Bergtold A, Freedman VH, Young RA, Kaplan G. Tumor necrosis factor a is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. Proc Natl Acad Sci USA. 1999;96:5657-5662.
6. Dastur DK, Udani PM. The pathology and pathogenesis of tuberculous encephalopathy. Acta Neuropathol (Berl). 1966;6:311-326.
7. Dastur DK, Manghani DK, Udani PM. Pathology and pathogenetic mechanisms in neurotuberculosis. Radiol Clin North Am. 1995;33:733-752.
8. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 2000;407:242-248.
9. van Bruggen N, Thibodeaux H, Palmer JT, et al. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest. 1999;104:1613-1620.
10. van der Flier M, Stockhammer G, Vonk GJ, et al. Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brain. J Infect Dis. 2001;183:149-153.
11. Matsuyama W, Hashiguchi T, Umehara F, et al. Expression of vascular endothelial growth factor in tuberculous meningitis. J Neurol Sci. 2001;186:75-79.
12. Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis. 1997;25:872-887.
13. Udani PM, Dastur DK. Tuberculous encephalopathy with and without meningitis. Clinical features and pathological correlations. J Neurol Sci. 1970;10:541-561.
14. Schoeman JF, Elshof JW, Laubscher JA, Janse van Rensburg A, Donald PR. The effect of adjuvant steroid treatment on serial cerebrospinal fluid changes in tuberculous meningitis. Ann Trop Paediatr. 2001;21:299-305.
15. Heiss JD, Papavassiliou E, Merrill MJ, et al. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats: involvement of the glucocorticoid receptor and vascular permeability factor. J Clin Invest. 1996;98:1400-1408.
16. Medical Research Council. Tuberculosis Trials Committee. Streptomycin treatment of tuberculous meningitis. Lancet. 1948;1:582-596.
17. Schoeman JF, le Roux D, Bezuidenhout PB, Donald PR. Intracranial pressure monitoring in tuberculous meningitis: clinical and computerized tomographic correlation. Dev Med Child Neurol. 1985;27:644-654.
18. Donald PR, Schoeman JF, Van Zyl LE, De Villiers JN, Pretorius M, Springer P. Intensive short course chemotherapy in the management of tuberculous meningitis. Int J Tuberc Lung Dis. 1998;2:704-711.
19. Verbon A, Kuijper S, Jansen HM, Speelman P, Kolk AH. Antigens in culture supernatant of Mycobacterium tuberculosis: epitopes defined by monoclonal and human antibodies. J Gen Microbiol. 1990;136(Pt 5): 955-964.
20. Wang W, Dentler WL, Borchardt RT. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol. 2001;280:H434-H440.
21. Feng D, Nagy JA, Dvorak HF, Dvorak AM. Vesiculo-vacuolar organelles and the regulation of venule permeability factor, histamine, and serotonin. J Exp Med. 1996;183:1981-1986.
22. Harrigan MR, Ennis SR, Masada T, Keep RF. Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema. Neurosurgery. 2002;50:589-598.
23. Proescholdt MA, Heiss JD, Walbridge S, et al. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neur. 1999;58:613-627.
24. Matsuyama W, Hashiguchi T, Matsumuro K, et al. Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis. Am J Respir Crit Care Med. 2000;162:1120-1122.
25. Abe Y, Nakamura M, Oshika Y, et al. Serum levels of vascular endothelial growth factor and cavity formation in active pulmonary tuberculosis. Respiration. 2001;68:490-500.
26. Slevin M, Krupinski J, Slowik A, Kumar P, Szczudlik A, Gaffney J. Serial measurement of vascular endothelial growth factor and transforming growth factor-β1 in serum of patients with acute ischemic stroke. Stroke. 2000;31:1863-1870.
27. Matsuyama W, Kubota R, Hashiguchi T, et al. Purified protein derivative of tuberculin upregulates the expression of vascular endothelial growth factor in T lymphocytes in vitro. Immunology. 2002;106:96-101.
28. Ragno S, Romano M, Howell S, Pappin DJ, Jenner PJ, Colston MJ. Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach. Immunology. 2001;104:99-108.
29. Donald PR, Schoeman JF, Beyers N, et al. Concentrations of interferon γ, tumor necrosis factor a, and interleukin-1β in the cerebrospinal fluid of children treated for tuberculous meningitis. Clin Infect Dis. 1995;21:924-929.
30. Mastroianni CM, Paoletti F, Lichtner M, D'Agostino C, Vullo V, Delia S. Cerebrospinal fluid cytokines in patients with tuberculous meningitis. Clin Immunol Immunopathol. 1997;84:171-176.
31. Mastroianni CM, Lancella L, Mengoni F, et al. Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyogenic and tuberculous meningitis. Clin Exp Immunol. 1998;114:210-214.
32. O'Toole RD, Thornton GF, Mukherjee MK, Nath RL. Dexamethasone in tuberculous meningitis: relationship of cerebrospinal fluid effects to therapeutic efficacy. Ann. Intern Med. 1969;70:39-48.